marginally significantp = 0.049
However, stage IV remains to be a strong independent predictor ( p < 0.001), with chemoradiotherapy (CRT) being marginally significant ( p = 0.049).
However, stage IV remains to be a strong independent predictor ( p < 0.001), with chemoradiotherapy (CRT) being marginally significant ( p = 0.049).